AP NEWS
Click to copy
Press release content from BusinessWire. The AP news staff was not involved in its creation.
Click to copy
PRESS RELEASE: Paid content from BusinessWire
Press release content from BusinessWire. The AP news staff was not involved in its creation.

Global Nucleic Acid Labeling (Biotin-based, Fluorescent, Radioactive, and Others) Market 2018-2023 - ResearchAndMarkets.com

October 2, 2018

DUBLIN--(BUSINESS WIRE)--Oct 2, 2018--The “Global Nucleic Acid Labeling Market - Segmented by Label Type (Biotin-based, Fluorescent, Radioactive, and Others), by Technique, by Application, and by Geography - Growth, Trends, and Forecast (2018 - 2023)” report has been added to ResearchAndMarkets.com’s offering.

The Nucleic Acid Labeling market is expected to register a CAGR of 9% over the forecast period

Nucleic acids are complex biomolecules that are responsible for the transfer of genetic information in all living organisms. Nucleic acid labeling is a procedure in which nucleic acids are modified or attached with tags that enable their detection or purification. Common labels used to generate nucleic acid probes include biotin, radioactive phosphates, fluorophores, and enzymes.

Factors such as rising genomic and enzymology research, advancements in tools for synthetic genome design, and the growing trend of personalized medicine are contributing to the growth of the market. However, high cost, complexity of techniques, and the lack of skilled professionals could adversely affect the market growth.

Personalized medicine aims to provide tailor-made therapies to individual patients, depending on the molecular basis of disease, has become popular over the recent years. The aging global population and the rising prevalence of chronic disease are factors that are putting unrelenting pressure on the capacity and financial viability of healthcare systems, across the world.

Personalized medicine holds the promise of providing better patient care and a high safety margin, while also lowering total healthcare costs. Rising demand for personalized medicine has created tremendous opportunities in the field of genetic medicine, and in order to exploit these opportunities, novel technologies are to be developed, which, in turn, has resulted in the rapid expansion of the nucleic acid labeling market.

Key Topics Covered:

1. Introduction

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

6. Market Dynamics

7. Market Segmentation

8. Key Players and Competitive Landscape

9. Future of the Market

Companies Mentioned

Enzo Biochem Inc. GE Healthcare Marker Gene Technologies Inc. Merck KGaA New England Biolabs Inc. PerkinElmer Inc. Promega Corporation Thermo Fisher Scientific Inc. Vector Laboratories Inc.

For more information about this report visit https://www.researchandmarkets.com/research/t3s9zb/global_nucleic?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181002005445/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Biotechnology

KEYWORD:

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 10/02/2018 05:38 AM/DISC: 10/02/2018 05:38 AM

http://www.businesswire.com/news/home/20181002005445/en

All contents © copyright 2019 The Associated Press. All rights reserved.